Cost-effectiveness of scaling up of hepatitis C screening and treatment: a modelling study in South Korea

Background The prices and the coverage of effective direct-acting antivirals (DAAs) to treat hepatitis C vary across countries. South Korea expanded DAAs coverage through national health insurance. This study aims to analyse the cost-effectiveness of scale-up of hepatitis C screening and treatment w...

Full description

Saved in:
Bibliographic Details
Main Authors: Rifat Atun, Jungyeon Kim, Markus Haacker, Salmaan Keshavjee
Format: Article
Language:English
Published: BMJ Publishing Group 2019-06-01
Series:BMJ Global Health
Online Access:https://gh.bmj.com/content/4/3/e001441.full
Tags: Add Tag
No Tags, Be the first to tag this record!